Cargando…
Bioavailability and Efficacy of a Gap Junction Enhancer (PQ7) in a Mouse Mammary Tumor Model
The loss of gap junctional intercellular communication is characteristic of neoplastic cells, suggesting that the restoration with a gap junction enhancer may be a new therapeutic treatment option with less detrimental effects than traditional antineoplastic drugs. A gap junction enhancer, 6-methoxy...
Autores principales: | Shishido, Stephanie N., Prasain, Keshar, Beck, Amanda, Nguyen, Thi D. T., Hua, Duy H., Nguyen, Thu Annelise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680495/ https://www.ncbi.nlm.nih.gov/pubmed/23776708 http://dx.doi.org/10.1371/journal.pone.0067174 |
Ejemplares similares
-
Induction of Apoptosis by PQ1, a Gap Junction Enhancer that Upregulates Connexin 43 and Activates the MAPK Signaling Pathway in Mammary Carcinoma Cells
por: Shishido, Stephanie N., et al.
Publicado: (2016) -
Gap Junction Enhancer Increases Efficacy of Cisplatin to Attenuate Mammary Tumor Growth
por: Shishido, Stephanie N., et al.
Publicado: (2012) -
The Effect of Antineoplastic Drugs in a Male Spontaneous Mammary Tumor Model
por: Shishido, Stephanie N., et al.
Publicado: (2013) -
Characterisation and antifungal activity of extracellular chitinase from a biocontrol fungus, Trichoderma asperellum PQ34
por: Loc, Nguyen Hoang, et al.
Publicado: (2019) -
Connexin 26 and Connexin 43 in Canine Mammary Carcinoma
por: Luu, Savannah, et al.
Publicado: (2019)